Thanks to CAR T-cell therapy, Dr. David Wellenstein's multiple myeloma has been controlled, allowing him to reclaim the joys of retirement and time with his family. March is Multiple Myeloma Awareness Month.
Read David's StoryCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreAdoptive cell therapy, also called cellular immunotherapy, dramatically increases the number of cancer-killing immune cells, boosting the immune system’s ability to seek and destroy cancer cells.
Read the ReportNearly 82,000 people in the United States were diagnosed with kidney cancer last year. Learn about this type of cancer, including treatment options.
Learn MoreResearch on the gut microbiome provides potential ways to diagnose early-onset colorectal cancer sooner, offer effective adjuvant therapy, and manage metastatic disease.
Learn More on the AACR BlogThe report highlights the AACR’s impact on the cancer community during the past year while advancing our mission to prevent and cure all cancers.
Read the ReportWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2024. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2023 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreA new wave of research-driven discoveries and technological innovations are delivering – and will propel additional – transformative advances to save more lives from cancer..
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More